<DOC>
	<DOC>NCT02803580</DOC>
	<brief_summary>The purpose of the present study is to evaluate the characteristics, management and clinical course of patients with IPF as treated under real-world in Italian Pulmonary Centres, in terms of symptoms, lung function and exercise tolerance during 12 months of observation.</brief_summary>
	<brief_title>IPF Italian Observational Study (FIBRONET) in Idiopathic Pulmonary Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
	<mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
	<criteria>Inclusion criteria: 1. Patients aged&gt;=40 years 2. Written informed consent to both participation in the study and privacy 3. Physician diagnosed IPF during the last 3 months based upon recent Americal Thoracic Society/European Resp. Society/Japanese Resp. Society/Latin American Thoracic Association guidelines 2011 (see Tables A1A2 for High Resolution Chest Computer Thomography and histology criteria): Exclusion of other known causes of Interstitial Lung Disease (e.g. domestic and occupational environmental exposures, connective tissue disease and drug toxicity) Assessment of Idiopathic Pulmonary Fibrosis based on HRCT or HRCT and surgical lung biopsy if available. 4. Patient with further followup possible with enrolling investigator during planned study period 5. Patients capable of discernment and able to read or write in Italian language. Exclusion criteria: 1. Inclusion in clinical trials or other IPF/ILD registries 2. Lung transplantation expected within the next 6 months 3. Pregnancy or breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>